F. Sakamaki et al., Correlation between severity of pulmonary arterial hypertension and I-123-metaiodobenzylguanidine left ventricular imaging, J NUCL MED, 41(7), 2000, pp. 1127-1133
Citations number
26
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
It remains unclear whether cardiac sympathetic nervous function is disturbe
d in patients with pulmonary arterial hypertension (PH) and how sympathetic
dysfunction is related to PH. Methods: in this study, I-123-metaiodobenzyl
guanidine (MIBG) imaging of the heart, which reveals the sympathetic innerv
ation of the left ventricle, was performed in 7 healthy volunteers without
cardiopulmonary disease (control subjects); 55 patients with PH, including
27 with chronic thromboembolic pulmonary hypertension (CTEPH) of major vess
els; and 28 patients with primary pulmonary hypertension (PPH). Results: Ca
rdiac I-123-MIBG uptake, assessed as the heart-to-mediastinum activity rati
o (H/M), was significantly lower in the CTEPH and PPH groups compared with
that in the control group (P < 0.01), Myocardial MIBG turnover, expressed a
s the washout rate (WR [%]) from 15 to 240 min, was significantly higher in
the CTEPH and PPH groups than that in the control group (P < 0.01). In the
PPH group, H/M and WR values of MIBG correlated with the severity of pulmo
nary hypertension (represented by total pulmonary vascular resistance deter
mined by right heart catheterization), the right ventricular ejection fract
ion determined by electron beam CT, and other variables but did not correla
te well in the CTEPH group. In both groups, patients with H/M greater than
or equal to 2.0 showed better cumulative survival than did those with H/M <
2.0 (P < 0.05). Conclusion: Patients with PH have significant left ventric
ular myocardial sympathetic nervous alteration. I-123-MIBG imaging of the h
eart is useful for assessing the severity of pulmonary hypertension caused
by PPH or CTEPH.